Reuters logo
BRIEF-Oxford Biodynamics inks development deal with two pharma firms
May 23, 2017 / 6:31 AM / 7 months ago

BRIEF-Oxford Biodynamics inks development deal with two pharma firms

May 23 (Reuters) - Oxford Biodynamics Plc:

* Entered into development deal with two of top 10 global pharmaceutical companies, that are collaborating on an anti pd-l1 therapy

* Agreement has potential to be extended in form of a licensing agreement Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +91 806 749 1136)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below